Khalid Alzoman

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Our ability to identify germline variants in hereditary cancer cases remains challenged by the incomplete cataloging of relevant genes and lack of consensus on who should be tested. We designed a panel [hereditary oncogenesis predisposition evaluation (HOPE)] that encompasses most of the genes known to be associated with cancer development and tested its(More)
  • 1